心房颤动与心力衰竭双重流行的治疗考量
Treatment Considerations for a Dual Epidemic of Atrial Fibrillation and Heart Failure.
作者信息
Sharma Parikshit S, Callans David J
机构信息
Dr. Sharma- Cardiology Fellow, Wright Center for Graduate Medical Education, Scranton, PA; Associate Professor of Medicine, The Commonwealth Medical College, Scranton, PA.Dr. Callans- Professor of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA.
出版信息
J Atr Fibrillation. 2013 Aug 31;6(2):740. doi: 10.4022/jafib.740. eCollection 2013 Aug-Sep.
Abstract
Atrial fibrillation (AF) and heart failure (HF) have emerged as major cardiovascular epidemics in developed nations over the past decade. They share similar risk factors, seem to mutually accelerate progression and are associated with increased morbidity and mortality. Their relationship involves complex hemodynamic, neuro-hormonal, inflammatory and electrophysiologic mechanisms, which go beyond just mutual risk factors. This review focuses on updates in AF and HF with a hope of better understanding this relationship and the management of this complex duo.
摘要
在过去十年中，心房颤动（AF）和心力衰竭（HF）已成为发达国家主要的心血管流行病。它们具有相似的危险因素，似乎相互加速病情进展，且与发病率和死亡率增加相关。它们之间的关系涉及复杂的血流动力学、神经激素、炎症和电生理机制，这不仅仅是共同的危险因素。本综述重点关注心房颤动和心力衰竭的最新进展，以期更好地理解这种关系以及对这一复杂组合的管理。
相似文献
1
Treatment Considerations for a Dual Epidemic of Atrial Fibrillation and Heart Failure.心房颤动与心力衰竭双重流行的治疗考量
J Atr Fibrillation. 2013 Aug 31;6(2):740. doi: 10.4022/jafib.740. eCollection 2013 Aug-Sep.
2
Left Atrial Appendage Thrombus Despite Anticoagulation.尽管进行了抗凝治疗，左心耳仍出现血栓。
J Atr Fibrillation. 2013 Jun 30;6(1):865. doi: 10.4022/jafib.865. eCollection 2013 Jun-Jul.
3
Management strategies in atrial fibrillation in patients with heart failure.心力衰竭合并心房颤动的管理策略。
Cardiol Rev. 2012 Nov-Dec;20(6):288-96. doi: 10.1097/CRD.0b013e31825dcf9b.
4
Atrial fibrillation in heart failure in the older population.老年人心力衰竭中的心房颤动。
Heart Fail Clin. 2013 Oct;9(4):451-9, viii-ix. doi: 10.1016/j.hfc.2013.07.007.
5
Atrial fibrillation in heart failure: a comprehensive review.心力衰竭中的心房颤动：全面综述。
Am J Med. 2010 Mar;123(3):198-204. doi: 10.1016/j.amjmed.2009.06.033.
6
Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.左心室射血分数正常或降低的心房颤动患者的心力衰竭进展及死亡率
J Interv Card Electrophysiol. 2019 Sep;55(3):325-331. doi: 10.1007/s10840-019-00534-x. Epub 2019 Mar 18.
7
Epidemiology of Atrial Fibrillation and Heart Failure: A Growing and Important Problem.心房颤动与心力衰竭的流行病学：一个日益严重且重要的问题。
Cardiol Clin. 2019 May;37(2):119-129. doi: 10.1016/j.ccl.2019.01.001. Epub 2019 Feb 22.
8
Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction.心力衰竭伴射血分数降低患者的房颤类型与结局。
J Am Coll Cardiol. 2017 Nov 14;70(20):2490-2500. doi: 10.1016/j.jacc.2017.09.027.
9
Electrical treatment of atrial arrhythmias in heart failure patients implanted with a dual defibrillator CRT device. Results from the TRADE-HF study.植入双腔除颤器心脏再同步化治疗（CRT）装置的心力衰竭患者房性心律失常的电治疗。TRADE-HF研究结果
Int J Cardiol. 2017 Jun 1;236:181-186. doi: 10.1016/j.ijcard.2017.01.101. Epub 2017 Jan 19.
10
Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study.在结构性正常心脏的心房颤动首次诊断后发生心力衰竭的预测因素和预后意义：贝尔格莱德心房颤动研究。
Eur J Heart Fail. 2013 Apr;15(4):415-24. doi: 10.1093/eurjhf/hft004. Epub 2013 Jan 9.
引用本文的文献
1
Metabolomics in Atrial Fibrillation: Unlocking Novel Biomarkers and Pathways for Diagnosis, Prognosis, and Personalized Treatment.心房颤动中的代谢组学：揭示用于诊断、预后和个性化治疗的新型生物标志物和途径。
J Clin Med. 2024 Dec 25;14(1):34. doi: 10.3390/jcm14010034.
2
Intermedin 1-53 Ameliorates Atrial Fibrosis and Reduces Inducibility of Atrial Fibrillation via TGF-β1/pSmad3 and Nox4 Pathway in a Rat Model of Heart Failure.在心力衰竭大鼠模型中，中介素1-53通过TGF-β1/pSmad3和Nox4信号通路改善心房纤维化并降低心房颤动的易感性。
J Clin Med. 2023 Feb 15;12(4):1537. doi: 10.3390/jcm12041537.
3
Metabolomics of the tryptophan-kynurenine degradation pathway and risk of atrial fibrillation and heart failure: potential modification effect of Mediterranean diet.色氨酸-犬尿氨酸降解途径的代谢组学与心房颤动和心力衰竭风险：地中海饮食的潜在修饰作用。
Am J Clin Nutr. 2021 Nov 8;114(5):1646-1654. doi: 10.1093/ajcn/nqab238.
4
The Predictive Value of Tissue Doppler Indices for Early Recurrence of Atrial Fibrillation After Electrical Cardioversion.组织多普勒指数对电复律后心房颤动早期复发的预测价值。
Clin Interv Aging. 2020 Oct 7;15:1917-1925. doi: 10.2147/CIA.S263303. eCollection 2020.
本文引用的文献
1
Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007.1993 - 2007年医疗保险受益人心房颤动的发病率、患病率及相关死亡率
Circ Cardiovasc Qual Outcomes. 2012 Jan;5(1):85-93. doi: 10.1161/CIRCOUTCOMES.111.962688. Epub 2012 Jan 10.
2
Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association.执行摘要：《2012年心脏病和中风统计数据更新：美国心脏协会报告》
Circulation. 2012 Jan 3;125(1):188-97. doi: 10.1161/CIR.0b013e3182456d46.
3
Dronedarone in high-risk permanent atrial fibrillation.盐酸决奈达隆治疗高危持续性心房颤动
N Engl J Med. 2011 Dec 15;365(24):2268-76. doi: 10.1056/NEJMoa1109867. Epub 2011 Nov 14.
4
Atrial fibrillation and mortality in heart failure: a community study.心房颤动与心力衰竭患者的死亡率：一项社区研究。
Circ Heart Fail. 2011 Nov;4(6):740-6. doi: 10.1161/CIRCHEARTFAILURE.111.962688. Epub 2011 Sep 15.
5
Atrial fibrillation and heart failure parallels: lessons for atrial fibrillation prevention.心房颤动与心力衰竭的相似之处：预防心房颤动的经验教训。
Crit Pathw Cardiol. 2011 Mar;10(1):46-51. doi: 10.1097/HPC.0b013e31820e1a4b.
6
Prevention of atrial fibrillation with omega-3 fatty acids: a meta-analysis of randomised clinical trials.用 ω-3 脂肪酸预防心房颤动：随机临床试验的荟萃分析。
Heart. 2011 Jul;97(13):1034-40. doi: 10.1136/hrt.2010.215350. Epub 2011 Apr 8.
7
Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials.他汀类药物对心房颤动的影响：来自随机对照试验的已发表和未发表证据的荟萃分析。
BMJ. 2011 Mar 16;342:d1250. doi: 10.1136/bmj.d1250.
8
Irbesartan in patients with atrial fibrillation.厄贝沙坦治疗心房颤动患者。
N Engl J Med. 2011 Mar 10;364(10):928-38. doi: 10.1056/NEJMoa1008816.
9
Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: a systematic review and meta-analysis.心脏再同步治疗在伴有和不伴有心房颤动的患者中的结局：系统评价和荟萃分析。
Heart Rhythm. 2011 Jul;8(7):1088-94. doi: 10.1016/j.hrthm.2011.02.014. Epub 2011 Feb 19.
10
Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association.预测美国心血管疾病的未来：美国心脏协会的政策声明。
Circulation. 2011 Mar 1;123(8):933-44. doi: 10.1161/CIR.0b013e31820a55f5. Epub 2011 Jan 24.
Zotero 插件